# Clinical Observation of Luspatercept in Treatment of Chinese Adult β-thalassaemia Patients With TD β-thalassemia

> **NCT06164821** · NA · UNKNOWN · sponsor: **Hematology department of the 920th hospital** · enrollment: 10 (estimated)

## Conditions studied

- Effect of Drug

## Interventions

- **DRUG:** luspatercept

## Key facts

- **NCT ID:** NCT06164821
- **Lead sponsor:** Hematology department of the 920th hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-01-01
- **Primary completion:** 2024-01-01
- **Final completion:** 2024-11-30
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2023-12-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06164821

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06164821, "Clinical Observation of Luspatercept in Treatment of Chinese Adult β-thalassaemia Patients With TD β-thalassemia". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT06164821. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*